Navigation Links
Scientists unravel the mystery of marine methane oxidation

This press release is available in German.

Microbiologists and geochemists from the Max Planck Institute for Marine Microbiology, along with their colleagues from Vienna and Mainz, show that marine methane oxidation coupled to sulfate respiration can be performed by a single microorganism, a member of the ancient kingdom of the Archaea, and does not need to be carried out in collaboration with a bacterium, as previously thought. They published their discovery as an article in the renowned scientific journal Nature.

Vast amounts of methane are stored under the ocean floor. Anaerobic oxidation of methane coupled to sulfate respiration (AOM) prevents the release of this potent greenhouse gas into the atmosphere. Although the process was discovered 35 years ago it has remained a long standing mystery as to how microorganisms perform this reaction. A decade ago, an important discovery was made which showed that two different microorganisms are often associated with AOM. It was proposed that these two microorganisms perform different parts of the AOM reaction. One, an archaeon, was supposed to oxidize methane and the other, a bacterium, was supposed to respire sulfate. This implied the existence of an intermediate compound to be shuttled from the methane oxidizer to the sulfate respirer.

Now, the team around Professor Kuypers has turned this whole model on its head. They show that the archaeon not only oxidizes methane but can also respire sulfate and does not necessarily need the bacterial partner. It appears that the archaeon does not employ the common enzyme toolbox that other known sulfate-respiring microorganisms use, but relies on a different, unknown pathway.

The basis for this dramatic shift in thinking is the observation that elemental sulfur is formed and accumulates in the methane-oxidizing archaeon. "Using chromatographic and state-of-the-art spectroscopic techniques we found surprisingly high concentrations of elemental sulfur in our cultures", says Professor Marcel Kuypers and adds: "The single-cell techniques showed that the sulfur content in the methane-degrading archaeon was much higher than in the bacterium. Our experiments show that this sulfur is formed during sulfate respiration."

This finding begs the question: What does the bacterium do if the archaeon does both sulfate respiration and methane oxidation? "The bacteria actually make a living off of the elemental sulfur produced by the archaea," explains Jana Milucka, first author of the study. "The bacteria grow by splitting the elemental sulfur into sulfate and hydrogen sulfide. This is a form of fermentation, like the process that produces alcohol."

"Until now we have always had trouble explaining the occurrence of elemental sulfur in oxygen-free sediments," notes Tim Ferdelman, scientist at the MPI Bremen and coauthor on the publication. "Our discoveries not only provide a mechanism for marine methane oxidation but also cast a new light on the carbon and sulfur cycling in marine, methane-rich sediments."


Contact: Marcel Kuypers

Related biology news :

1. Scientists discover new method of gene identification
2. Weber State Scientists discover possible building blocks of ancient genetic systems
3. Space research institute awards postdoctoral fellowships to 4 scientists
4. Space research institute awards postdoctoral fellowships to four scientists
5. 3,000 insect scientists coming to Knoxville next week
6. Stem cell scientists discover potential way to expand cells for use with patients
7. Losing protein helps heart recover, say Temple scientists
8. Scientists and Google to keep an eye on environment
9. Scientists identify insect-repelling compounds in Jatropha
10. UCSB scientists report new beginning in split-brain research, using new analytical tools
11. Berkeley Lab scientists help develop promising therapy for Huntingtons disease
Post Your Comments:
Related Image:
Scientists unravel the mystery of marine methane oxidation
(Date:11/16/2015)... 2015  Synaptics Inc. (NASDAQ: SYNA ), ... announced expansion of its TDDI product portfolio with ... and display driver integration (TDDI) solutions designed to ... TDDI products add to the previously-announced TD4300 ... resolution), and TD4322 (FHD resolution) solutions. All four ...
(Date:11/10/2015)... LONDON , Nov. 10, 2015 /PRNewswire/ ... segmented on the basis of product, type, ... segments included in this report are consumables, ... this report are safety biomarkers, efficacy biomarkers, ... in this report are diagnostics development, drug ...
(Date:11/2/2015)... , Nov. 2, 2015  SRI International has ... to provide preclinical development services to the National Cancer ... SRI will provide scientific expertise, modern testing and support ... of preclinical pharmacology and toxicology studies to evaluate potential ... --> The PREVENT Cancer Drug Development Program is ...
Breaking Biology News(10 mins):
(Date:11/25/2015)... 2015 /PRNewswire/ - Aeterna Zentaris Inc. (NASDAQ:  AEZS; TSX: ... prospects remain fundamentally strong and highlights the following ... received DSMB recommendation to continue the ZoptEC Phase ... the final interim efficacy and safety data ... men with heavily pretreated castration- and Taxane-resistant prostate ...
(Date:11/25/2015)... ... November 25, 2015 , ... Jessica Richman and ... early in their initial angel funding process. Now, they are paying it forward ... make early stage investments in the microbiome space. In this, they join ...
(Date:11/24/2015)... , Nov. 24, 2015 Halozyme Therapeutics, Inc. (NASDAQ: ... Conference in New York on Wednesday, December ... Helen Torley , president and CEO, will provide a corporate overview. ... New York at 1:00 p.m. ET/10:00 a.m. PT . ... investor relations, will provide a corporate overview. --> th ...
(Date:11/24/2015)... 24, 2015 /PRNewswire/ - Aeterna Zentaris Inc. (NASDAQ:  AEZS) (TSX: ... behalf of the Toronto Stock Exchange, confirms that as ... no corporate developments that would cause the recent movements ... --> About Aeterna Zentaris Inc. ... --> Aeterna Zentaris is a specialty biopharmaceutical company ...
Breaking Biology Technology: